Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$962M |
| 2 |
AbbVie
ABBV
|
+$512M |
| 3 |
Bank of America
BAC
|
+$172M |
| 4 |
TJX Companies
TJX
|
+$157M |
| 5 |
GE Vernova
GEV
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$636M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$388M |
| 3 |
Palantir
PLTR
|
+$253M |
| 4 |
Applovin
APP
|
+$236M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.84% |
| 2 | Technology | 16.54% |
| 3 | Financials | 9.27% |
| 4 | Industrials | 6.9% |
| 5 | Healthcare | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SJT
3076
San Juan Basin Royalty Trust
SJT
$176M
| $2.02M | ﹤0.01% |
338,062
+40,363
| +14% | +$245K |
2024 Q4
2 quarters
|
|
3077
Fortune Brands Innovations
FBIN
$4.6B
| $2.02M | ﹤0.01% |
39,239
-9,343
| -19% | -$489K |
2024 Q4
2 quarters
|
|
|
GGN
3078
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$825M
| $2.02M | ﹤0.01% |
460,108
+133,037
| +41% | +$572K |
2024 Q4
2 quarters
|
|
3079
Sagimet Biosciences
SGMT
$582M
| $2.02M | ﹤0.01% |
264,675
-81,511
| -24% | -$344K |
2025 Q1
1 quarter
|
|
3080
Cohen & Steers Real Estate Opportunities and Income Fund
RLTY
$232M
| $2.02M | ﹤0.01% |
132,791
+2,059
| +2% | +$30.6K |
2024 Q4
2 quarters
|
|
3081
Aurinia Pharmaceuticals
AUPH
$2.12B
| $2.01M | ﹤0.01% |
237,088
+213,758
| +916% | +$1.71M |
2024 Q4
2 quarters
|
|
|
PFD
3082
Flaherty & Crumrine Preferred and Income Fund
PFD
$138M
| $2.01M | ﹤0.01% |
177,337
+6,569
| +4% | +$72.1K |
2024 Q4
2 quarters
|
|
3083
Innovator US Equity Buffer ETF July
BJUL
$360M
| $2M | ﹤0.01% |
42,375
+7,502
| +22% | +$330K |
2024 Q4
2 quarters
|
|
|
SOR
3084
Source Capital
SOR
$370M
| $1.99M | ﹤0.01% |
46,000
+2,165
| +5% | +$90.7K |
2024 Q4
2 quarters
|
|
|
VRNA
3085
DELISTED
Verona Pharma
VRNA
| $1.99M | ﹤0.01% |
21,048
+14,426
| +218% | +$1.07M |
2024 Q4
2 quarters
|
|
3086
iShares ESG Advanced High Yield Corporate Bond ETF
HYXF
$188M
| $1.99M | ﹤0.01% |
41,888
+264
| +0.6% | +$12.2K |
2024 Q4
2 quarters
|
|
3087
C3.ai
AI
$1.79B
| $1.99M | ﹤0.01% |
80,972
-2,336
| -3% | -$53.4K |
2024 Q4
2 quarters
|
|
3088
Enova International
ENVA
$4.27B
| $1.99M | ﹤0.01% |
17,830
-971
| -5% | -$92.7K |
2024 Q4
2 quarters
|
|
3089
America Movil
AMX
$62B
| $1.98M | ﹤0.01% |
110,577
+5,615
| +5% | +$93.3K |
2024 Q4
2 quarters
|
|
3090
Invesco BulletShares 2031 High Yield Corporate Bond ETF
BSJV
$123M
| $1.98M | ﹤0.01% |
74,155
+8,064
| +12% | +$210K |
2024 Q4
2 quarters
|
|
|
CCD
3091
Calamos Dynamic Convertible & Income Fund
CCD
$643M
| $1.97M | ﹤0.01% |
97,895
-1,996
| -2% | -$41.4K |
2024 Q4
2 quarters
|
|
3092
VanEck Pharmaceutical ETF
PPH
$994M
| $1.97M | ﹤0.01% |
22,417
+2,363
| +12% | +$205K |
2024 Q4
2 quarters
|
|
3093
iShares Global Utilities ETF
JXI
$369M
| $1.97M | ﹤0.01% |
26,668
+3,674
| +16% | +$262K |
2025 Q1
1 quarter
|
|
3094
Northern Trust Quality Dividend ETF
QDF
$2.19B
| $1.97M | ﹤0.01% |
26,882
-5,377
| -17% | -$368K |
2024 Q4
2 quarters
|
|
3095
Bausch + Lomb
BLCO
$6.05B
| $1.97M | ﹤0.01% |
151,155
-3,193
| -2% | -$38.4K |
2024 Q4
2 quarters
|
|
3096
Atlas Energy Solutions
AESI
$1.46B
| $1.96M | ﹤0.01% |
146,968
-18,263
| -11% | -$249K |
2024 Q4
2 quarters
|
|
3097
FT Vest US Equity Deep Buffer ETF January
DJAN
$482M
| $1.96M | ﹤0.01% |
48,703
+1,949
| +4% | +$75.1K |
2024 Q4
2 quarters
|
|
3098
JPMorgan BetaBuilders International Equity ETF
BBIN
$6.47B
| $1.96M | ﹤0.01% |
29,066
+14,628
| +101% | +$941K |
2024 Q4
2 quarters
|
|
3099
Sportsman's Warehouse
SPWH
$43.4M
| $1.96M | ﹤0.01% |
567,386
+267,995
| +90% | +$600K |
2024 Q4
2 quarters
|
|
3100
Ferrovial N.V. Ordinary Shares
FER
$38.1B
| $1.96M | ﹤0.01% |
36,884
+25,794
| +233% | +$1.26M |
2024 Q4
2 quarters
|
|
Similar funds
Raymond James Financial's Q2 2025 Portfolio in Review
As of Q2 2025, Raymond James Financial held 7,081 positions worth $290B, up 9.4% from $266B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Raymond James Financial's Q2 2025 filing shows 2,183 new, 2,404 increased, 2,172 reduced and 80 closed positions. Its largest new stake was ServiceTitan Inc: 369,922 shares worth $39.6M. The largest sale was Merck, an estimated $636M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, down from 40% a quarter earlier, followed by Technology and Financials.
- Raymond James Financial's largest Q2 2025 buy was ServiceTitan Inc: 369,922 shares worth $39.6M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $962M increase.
- Raymond James Financial's biggest Q2 2025 reduction was Merck, cutting an estimated $636M.
- Raymond James Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $36.8M.
- Raymond James Financial's ten largest holdings make up 22% of its $290B portfolio in Q2 2025.
- Raymond James Financial opened 2,183 new positions and closed 80 in Q2 2025.
- Raymond James Financial's portfolio value rose 9.4% quarter-over-quarter to $290B.
Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.